Marshall Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.04M Buy
8,386
+602
+8% +$206K 1.26% 27
2026
Q1
$2.74M Buy
7,784
+350
+5% +$125K 1.31% 26
2025
Q4
$2.43M Buy
7,434
+977
+15% +$310K 1.22% 29
2025
Q3
$1.82M Buy
+6,457
New +$1.87M 0.96% 37
2025
Q2
Sell
-6,210
Closed -$1.93M 30
2025
Q1
$1.93M Buy
6,210
+274
+5% +$80.9K 1.2% 32
2024
Q4
$1.91M Buy
+5,936
New +$1.76M 1.13% 34

Other funds holding AMGN

Marshall Investment Management's AMGN Position: Q2 2026 in Review

Marshall Investment Management increased its Amgen (AMGN) stake by 7.7% in Q2 2026, buying an estimated $206K and bringing the position to 8,386 shares worth $3.04M. The position accounts for 1.26% of the portfolio, ranked #27.

Marshall Investment Management first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Marshall Investment Management held 8,386 shares of Amgen worth $3.04M as of Q2 2026.
  • Marshall Investment Management bought 602 Amgen shares in Q2 2026, an estimated $206K.
  • Amgen made up 1.26% of Marshall Investment Management's portfolio in Q2 2026, its #27 holding.
  • Marshall Investment Management first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Marshall Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.